Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare intravenous furosemide (125 to 250 mg), isolated or
in combination with hypertonic saline solution (2.4% to 3.6%) in the outpatient heart failure
patient. The hypothesis is that the combination therapy will increase the diuresis volume at
3 hours and improve congestion parameters at 7 days.
Phase:
Phase 3
Details
Lead Sponsor:
Puerta de Hierro University Hospital
Collaborators:
Instituto de Salud Carlos III Spanish Society of Cardiology